Focus Diagnostics gets FDA clearance for H1N1 flu test

05/24/2010 | United Press International

The FDA has cleared Focus Diagnostics' Simplexa Influenza A H1N1 (2009) virus test, which can spot the virus in samples from nasal swabs or nasal aspirates. "With this clearance, the availability of Simplexa H1N1 test will not be affected when the public health emergency expires," said Dr. Jeffrey Shuren, director of the agency's Center for Devices and Radiological Health.

View Full Article in:

United Press International

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX